SAN ANTONIO -- Infliximab appears to be a valuable treatment for long-term management of pustular psoriasis, Dr. Rajat Varma said at the annual meeting of the American Academy of Dermatology.
In a patient who had a significant flare of severe pustular psoriasis that required hospitalization, infliximab (Remicade) treatment resulted in remarkable clearing.
The case was reported in 2002 by Dr. Boni E. Elewski (J. Am. Acad. Dermatol. 2002;47:796-7). This year, Dr. Varma reported on the patient's 7-year follow-up.
The patient was rest seen at age 44 years with 90% of his body surface area affected, and he was treated with 5 mg/kg of intravenous infliximab. His ...